These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8538940)

  • 21. Acute pancreatitis, acute hepatitis and acute renal failure favourably resolved in two renal transplant recipients.
    Voiculescu M; Ionescu C; Ismail G; Mandache E; Hortopan M; Constantinescu I; Iliescu O
    Rom J Gastroenterol; 2003 Mar; 12(1):41-6. PubMed ID: 12673379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of acute severe exacerbation of chronic hepatitis B with cyclosporin A and interferon-beta: a case report.
    Ishiwata N; Noguchi O; Koyama N; Sakamoto H; Hirata R; Enomoto N; Tanaka Y; Marumo F; Sato C
    Am J Gastroenterol; 1995 May; 90(5):853-4. PubMed ID: 7733115
    [No Abstract]   [Full Text] [Related]  

  • 23. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha therapy alters glucose metabolism in patients with chronic hepatitis B.
    Tanaka H; Shiota G; Kawasaki H
    J Med; 1997; 28(5-6):325-34. PubMed ID: 9604791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute renal failure as a complication of acute viral hepatitis].
    Otero González A; Vega M; Santos C; Jiménez JL; Temes Montes XL; Sánchez Guisande D
    Med Clin (Barc); 1984 Mar; 82(9):424-5. PubMed ID: 6717158
    [No Abstract]   [Full Text] [Related]  

  • 26. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B].
    Yoo BC; Kim HJ; Do JH; Park SM
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome during treatment with interferon alpha for hepatitis B.
    Boz C; Ozmenoglu M; Aktoz G; Velioglu S; Alioglu Z
    J Clin Neurosci; 2004 Jun; 11(5):523-5. PubMed ID: 15177399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Exacerbation of ulcerative colitis and chronic hepatitis by the treatment with interferon for chronic hepatitis B].
    Yasumori K; Aramaki T; Mizuta Y; Nomoto T; Mukai N; Tanaka Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 Jul; 92(7):1066-70. PubMed ID: 7643461
    [No Abstract]   [Full Text] [Related]  

  • 31. [How to follow treated and untreated chronic hepatitis B and C].
    Adler M; Golstein P; Botembe N; Bourgeois N
    Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liverbiopsy because of Hbs Ag positive hepatitis revealing a non-suspected hepatic schistosomiasis. Implication for future therapy with recombinant alpha interferon?
    Loffeld RJ; Blaauboer J; Blak AG
    Acta Gastroenterol Latinoam; 1996; 26(1):35-7. PubMed ID: 9137655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
    Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
    Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 35. Exacerbation of type 2 diabetes mellitus during interferon-alfa therapy for chronic hepatitis B.
    Lopes EP; Oliveira PM; Silva AE; Ferraz ML; Costa CH; Miranda W; Dib SA
    Lancet; 1994 Jan; 343(8891):244. PubMed ID: 7904708
    [No Abstract]   [Full Text] [Related]  

  • 36. [Management of chronic hepatitis B].
    Telegdy L
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1462-5. PubMed ID: 9221375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
    Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
    Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural human interferon alpha may act differently when given parenterally or orally to patients chronically infected with hepatitis B virus.
    Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):11-22. PubMed ID: 8874764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute renal failure in hepatitis B].
    Marcos Sánchez F; Turabián Fernández JL; Serra Estellés M; Durán Pérez-Navarro A
    Rev Clin Esp; 1985 Feb; 176(2):106. PubMed ID: 3991946
    [No Abstract]   [Full Text] [Related]  

  • 40. Exacerbation of chronic hepatitis D during interferon alpha administration.
    Crosignani A; Invernizzi P; Ferrari R; Manzin A; Bruno S; Zuin M; Bianchi FB; Podda M
    Ital J Gastroenterol Hepatol; 1999; 31(1):66-9. PubMed ID: 10091106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.